ARAY - Accuray Incorporated logo

Accuray Incorporated

ARAY

Accuray Incorporated designs and manufactures radiosurgery and radiation therapy systems for tumor treatment. Its primary products include the CyberKnife and TomoTherapy platforms, which serve hospitals and treatment facilities worldwide.

βš•οΈ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 10 years ago β†’$44today

Score Overview

1 Year
Score
Net Growth-28x
Net TrendShrank
Net Income Consistencyβ€”
Rev Growth-12.34%
Rev TrendShrank
Revenue Consistencyβ€”
5 Years
Score3.2
Net Growth-5x
Net Trend40%
Net Income Consistencyβ€”
Rev Growth1.43%
Rev Trend60%
Revenue Consistencyβ€”
10 Years
Score
Net Growth-92.89%
Net Trend50%
Net Income Consistency
Rev Growth0.79%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-6x
Net Trend47%
Net Income Consistency
Rev Growth186.18%
Rev Trend68%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Accuray Incorporated has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • ARAY

2018: 84.6% Β· 2021: 71.8% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-02
$ 0.28β€”
1 Year2025-10-02
$ 1.65-82.97%
5 Years2021-10-01
$ 4.06-93.08%
10 Years2016-09-30
$ 6.37-95.59%
All Time2007-02-08
$ 28.47-99.01%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
2026$ 401M-$ 49M
2025$ 458M-$ 1M$ 57M
2024$ 446M-$ 15M$ 68M
2023$ 447M-$ 9M$ 89M
2022$ 429M-$ 5M$ 88M
2021$ 396M-$ 6M$ 116M
2020$ 382M$ 3M$ 107M
2019$ 418M-$ 16M$ 76M
2018$ 404M-$ 23M$ 83M
2017$ 383M-$ 29M$ 95M
2016$ 398M-$ 25M$ 167M
2015$ 379M-$ 40M$ 143M
2014$ 369M-$ 35M$ 171M
2013$ 315M-$ 103M$ 174M
2012$ 409M-$ 72M$ 143M
2011$ 222M-$ 26M$ 95M
2010$ 221M$ 2M$ 145M
2009$ 233M$ 609K$ 101M
2008$ 210M$ 5M$ 122M
IPO2007$ 140M-$ 5M$ 204M
ARAY - Accuray Incorporated logo

Accuray Incorporated fundamental performance

Between 2021 and 2026, revenue grew from $ 396M to $ 401M and net income went from -$ 6M to -$ 49M. Revenue increased in 3 of those 5 years; net income in 2.

Across Accuray Incorporated's full reported history, from 2007 to 2026, revenue grew from $ 140M to $ 401M and net income went from -$ 5M to -$ 49M. Revenue increased in 68% of the years measured; net income in 47%.

Accuray Incorporated currently holds a 5-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Continue ARAY’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies